一个比髓瘤更大的战士
1Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.
概括
多发性骨髓瘤不成比例地影响少数群体. 这位患者的旅程突出了医疗保健中持续存在的公民自由问题,强调了在健康公平方面继续取得进展的必要性.
科学领域:
- 在瘤学瘤学.
- 健康 公平 卫生 公平
- 医学中的公民自由.
背景情况:
- 多发性骨髓瘤是血细胞的癌症,通常在发病率和结果上表现出显著的种族和民族差异.
- 解决健康差异对于公平的癌症护理和患者倡导至关重要.
研究的目的:
- 为了说明多发性骨髓瘤诊断与公民自由和健康公平等更广泛问题的交叉点.
- 使用患者叙事来强调医疗保健平等的进展和剩余挑战.
主要方法:
- 一个案例研究方法,详细介绍患者患有多发性骨髓瘤的经验.
- 在公民自由和获得医疗保健的背景下,对患者旅程的定性分析.
主要成果:
- 患者的诊断和治疗途径揭示了系统性不平等.
- 叙事作为一个强有力的提醒,历史和当代的公民自由问题在医疗保健提供.
结论:
- 患者的故事对于理解健康差异对人类的影响至关重要.
- 在瘤学中实现真正的健康公平需要对公民自由和社会正义的持续承诺.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


